These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 851762)

  • 61. Medicine and the media: side effects on television.
    Dixon B
    Br J Hosp Med; 1978 Aug; 20(2):208. PubMed ID: 698473
    [No Abstract]   [Full Text] [Related]  

  • 62. Role of medical journals in adverse drug reaction alerts.
    Lancet; 1985 Oct; 2(8459):836. PubMed ID: 2864557
    [No Abstract]   [Full Text] [Related]  

  • 63. Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.
    Scott HD; Thacher-Renshaw A; Rosenbaum SE; Waters WJ; Green M; Andrews LG; Faich GA
    JAMA; 1990 Apr; 263(13):1785-8. PubMed ID: 2313850
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Primum non nocere.
    Gifford RW
    JAMA; 1977 Aug; 238(7):589-90. PubMed ID: 577959
    [No Abstract]   [Full Text] [Related]  

  • 65. Monitored drug usage in a hospital environment.
    Macgregor AG
    N Z Med J; 1969 Jun; 69(445):356-9. PubMed ID: 5257555
    [No Abstract]   [Full Text] [Related]  

  • 66. Special section. The evaluation of drugs: an international perspective.
    Int J Technol Assess Health Care; 1986; 2(4):613-708. PubMed ID: 10280881
    [No Abstract]   [Full Text] [Related]  

  • 67. [Rational introduction to new drugs requires both a health care and a community perspective].
    Gustafsson LL; Wettermark B; Kalin M; Korkmaz S; Persson ME; Almkvist H; Hjemdahl P; Julander M; Kristianson K; Ringertz B; Bergendahl GT; Wiking N
    Lakartidningen; 2009 Jan 7-13; 106(1-2):52. PubMed ID: 19235325
    [No Abstract]   [Full Text] [Related]  

  • 68. Post-marketing surveillance.
    Lasagna L
    Triangle; 1980; 19(3-4):107-11. PubMed ID: 7013216
    [No Abstract]   [Full Text] [Related]  

  • 69. Likely photosensitizing agents available in the United Kingdom--an update.
    Bellaney GJ; Proby CM; Hawk JL
    Clin Exp Dermatol; 1996 Jan; 21(1):14-16. PubMed ID: 8689761
    [No Abstract]   [Full Text] [Related]  

  • 70. Therapeutic misadventure.
    Br Med J; 1968 Mar; 1(5594):724. PubMed ID: 5641433
    [No Abstract]   [Full Text] [Related]  

  • 71. Assessing the safety of medicines.
    Mansel-Jones D
    J R Coll Gen Pract; 1973 Jun; 23 Suppl 2(Suppl 2):67-70. PubMed ID: 4766237
    [No Abstract]   [Full Text] [Related]  

  • 72. Discovery of new adverse drug reactions. A review of the Food and Drug Administration's spontaneous reporting system.
    Rossi AC; Knapp DE
    JAMA; 1984 Aug 24-31; 252(8):1030-3. PubMed ID: 6748207
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The hazards of drugs.
    Wade OL
    J Ir Med Assoc; 1965 Oct; 57(340):101-6. PubMed ID: 5826994
    [No Abstract]   [Full Text] [Related]  

  • 74. New DTCA Guidance--Enough to Empower Consumers?
    Robertson CT
    N Engl J Med; 2015 Sep; 373(12):1085-7. PubMed ID: 26287748
    [No Abstract]   [Full Text] [Related]  

  • 75. Adverse drug reactions--a plea for a realistic attitude.
    Böttiger LE
    Acta Med Scand; 1979; 205(6):449-50. PubMed ID: 452937
    [No Abstract]   [Full Text] [Related]  

  • 76. New law in Germany compensates patients for drug side-effects.
    Orellana C
    Lancet; 2002 Aug; 360(9331):471. PubMed ID: 12241734
    [No Abstract]   [Full Text] [Related]  

  • 77. Post-marketing surveillance of new medicines.
    Smithells RW
    Br Med J; 1977 Nov; 2(6096):1218. PubMed ID: 589095
    [No Abstract]   [Full Text] [Related]  

  • 78. Laboratory study of drug-related performance changes.
    Burns M; Wilkinson CJ
    J Occup Med; 1990 Apr; 32(4):320-6. PubMed ID: 2335798
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Structured introduction of new drug therapies: valuable initiative--transparency required].
    Lundkvist J; Henriksson F
    Lakartidningen; 2009 Jan 7-13; 106(1-2):51. PubMed ID: 19235324
    [No Abstract]   [Full Text] [Related]  

  • 80. Why not monitor our patients for adverse effects of drugs?
    Martys CR
    J R Coll Gen Pract; 1981 Jul; 31(228):435. PubMed ID: 7320990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.